Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

NCT00004645 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
22
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborators